FDA Inspection
Maitland Labs of Central FloridaMaitland Labs of Central Florida – FDA Inspection, Jun 17, 2019
Record Details
This FDA Inspection record concerns Maitland Labs of Central Florida, with an inspection on June 17, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · a766690e-60c4-4e03-a08a-5d2b6d9a832f
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1093172
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
9- 21 CFR 211.42(c)(10)(v)Cleaning System
- 21 CFR 211.42(c)(10)(iv)Environmental Monitoring System
- 21 CFR 211.167(a)Sterility/pyrogen-free testing
- 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
- 21 CFR 211.113(b)Validation lacking for sterile drug products
- 21 CFR 211.165(a)Testing and release for distribution
- FDCA 503B(a)(10)Container label, outsourcer facility
- FDCA 503B(a)(10)Drug product label, outsourcer facility
- 21 CFR 211.166(a)Lack of written stability program
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Maitland Labs of Central Florida
1| Date | Classification | Office | Project area |
|---|---|---|---|
| February 28, 2020 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Maitland Labs of Central Florida
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.